nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—MAOA—Zonisamide—epilepsy syndrome	0.16	0.455	CbGbCtD
Zolmitriptan—CYP1A2—Carbamazepine—epilepsy syndrome	0.0389	0.111	CbGbCtD
Zolmitriptan—CYP1A2—Primidone—epilepsy syndrome	0.0363	0.103	CbGbCtD
Zolmitriptan—CYP1A2—Propofol—epilepsy syndrome	0.0326	0.0926	CbGbCtD
Zolmitriptan—CYP1A2—Phenobarbital—epilepsy syndrome	0.0311	0.0885	CbGbCtD
Zolmitriptan—CYP1A2—Diazepam—epilepsy syndrome	0.0295	0.0839	CbGbCtD
Zolmitriptan—CYP1A2—Valproic Acid—epilepsy syndrome	0.0233	0.0662	CbGbCtD
Zolmitriptan—HTR1D—meninx—epilepsy syndrome	0.0202	0.196	CbGeAlD
Zolmitriptan—MAOA—locus ceruleus—epilepsy syndrome	0.00745	0.0723	CbGeAlD
Zolmitriptan—HTR1F—ganglion—epilepsy syndrome	0.00728	0.0707	CbGeAlD
Zolmitriptan—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00479	0.0465	CbGeAlD
Zolmitriptan—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00464	0.045	CbGeAlD
Zolmitriptan—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00387	0.0375	CbGeAlD
Zolmitriptan—HTR1F—forebrain—epilepsy syndrome	0.00305	0.0297	CbGeAlD
Zolmitriptan—HTR1B—ganglion—epilepsy syndrome	0.00298	0.029	CbGeAlD
Zolmitriptan—HTR1D—ganglion—epilepsy syndrome	0.00289	0.028	CbGeAlD
Zolmitriptan—HTR1F—telencephalon—epilepsy syndrome	0.00281	0.0273	CbGeAlD
Zolmitriptan—HTR1A—ganglion—epilepsy syndrome	0.00241	0.0234	CbGeAlD
Zolmitriptan—MAOA—ganglion—epilepsy syndrome	0.0022	0.0214	CbGeAlD
Zolmitriptan—HTR1A—hindbrain—epilepsy syndrome	0.00183	0.0177	CbGeAlD
Zolmitriptan—HTR1F—head—epilepsy syndrome	0.00175	0.017	CbGeAlD
Zolmitriptan—MAOA—hindbrain—epilepsy syndrome	0.00167	0.0162	CbGeAlD
Zolmitriptan—HTR1F—nervous system—epilepsy syndrome	0.00166	0.0161	CbGeAlD
Zolmitriptan—HTR1F—central nervous system—epilepsy syndrome	0.0016	0.0155	CbGeAlD
Zolmitriptan—Sumatriptan—SLCO1A2—epilepsy syndrome	0.00141	0.288	CrCbGaD
Zolmitriptan—HTR1B—brainstem—epilepsy syndrome	0.0013	0.0126	CbGeAlD
Zolmitriptan—HTR1F—brain—epilepsy syndrome	0.00127	0.0123	CbGeAlD
Zolmitriptan—HTR1D—brainstem—epilepsy syndrome	0.00126	0.0122	CbGeAlD
Zolmitriptan—HTR1B—forebrain—epilepsy syndrome	0.00125	0.0122	CbGeAlD
Zolmitriptan—HTR1D—forebrain—epilepsy syndrome	0.00121	0.0118	CbGeAlD
Zolmitriptan—HTR1B—telencephalon—epilepsy syndrome	0.00115	0.0112	CbGeAlD
Zolmitriptan—HTR1D—telencephalon—epilepsy syndrome	0.00111	0.0108	CbGeAlD
Zolmitriptan—HTR1A—brainstem—epilepsy syndrome	0.00105	0.0102	CbGeAlD
Zolmitriptan—HTR1A—forebrain—epilepsy syndrome	0.00101	0.0098	CbGeAlD
Zolmitriptan—MAOA—brainstem—epilepsy syndrome	0.000956	0.00928	CbGeAlD
Zolmitriptan—HTR1A—telencephalon—epilepsy syndrome	0.000929	0.00902	CbGeAlD
Zolmitriptan—MAOA—forebrain—epilepsy syndrome	0.000923	0.00896	CbGeAlD
Zolmitriptan—MAOA—telencephalon—epilepsy syndrome	0.000848	0.00824	CbGeAlD
Zolmitriptan—HTR1B—midbrain—epilepsy syndrome	0.000826	0.00802	CbGeAlD
Zolmitriptan—HTR1B—spinal cord—epilepsy syndrome	0.000806	0.00783	CbGeAlD
Zolmitriptan—HTR1D—midbrain—epilepsy syndrome	0.0008	0.00777	CbGeAlD
Zolmitriptan—HTR1B—head—epilepsy syndrome	0.000717	0.00696	CbGeAlD
Zolmitriptan—HTR1D—head—epilepsy syndrome	0.000694	0.00674	CbGeAlD
Zolmitriptan—HTR1B—nervous system—epilepsy syndrome	0.000679	0.0066	CbGeAlD
Zolmitriptan—HTR1A—midbrain—epilepsy syndrome	0.000667	0.00647	CbGeAlD
Zolmitriptan—MAOA—medulla oblongata—epilepsy syndrome	0.000667	0.00647	CbGeAlD
Zolmitriptan—HTR1D—nervous system—epilepsy syndrome	0.000658	0.00639	CbGeAlD
Zolmitriptan—HTR1B—central nervous system—epilepsy syndrome	0.000654	0.00635	CbGeAlD
Zolmitriptan—HTR1A—spinal cord—epilepsy syndrome	0.000651	0.00632	CbGeAlD
Zolmitriptan—HTR1D—central nervous system—epilepsy syndrome	0.000633	0.00615	CbGeAlD
Zolmitriptan—Eletriptan—HTR7—epilepsy syndrome	0.00061	0.125	CrCbGaD
Zolmitriptan—MAOA—midbrain—epilepsy syndrome	0.000609	0.00592	CbGeAlD
Zolmitriptan—Sumatriptan—ABCG2—epilepsy syndrome	0.000595	0.122	CrCbGaD
Zolmitriptan—MAOA—spinal cord—epilepsy syndrome	0.000594	0.00577	CbGeAlD
Zolmitriptan—HTR1A—head—epilepsy syndrome	0.000578	0.00561	CbGeAlD
Zolmitriptan—HTR1A—nervous system—epilepsy syndrome	0.000548	0.00532	CbGeAlD
Zolmitriptan—MAOA—head—epilepsy syndrome	0.000528	0.00513	CbGeAlD
Zolmitriptan—HTR1A—central nervous system—epilepsy syndrome	0.000528	0.00512	CbGeAlD
Zolmitriptan—HTR1B—brain—epilepsy syndrome	0.000519	0.00504	CbGeAlD
Zolmitriptan—HTR1A—cerebellum—epilepsy syndrome	0.000516	0.00501	CbGeAlD
Zolmitriptan—HTR1D—brain—epilepsy syndrome	0.000503	0.00488	CbGeAlD
Zolmitriptan—MAOA—nervous system—epilepsy syndrome	0.000501	0.00486	CbGeAlD
Zolmitriptan—Almotriptan—CYP2C19—epilepsy syndrome	0.000486	0.0993	CrCbGaD
Zolmitriptan—MAOA—central nervous system—epilepsy syndrome	0.000482	0.00468	CbGeAlD
Zolmitriptan—MAOA—cerebellum—epilepsy syndrome	0.000471	0.00458	CbGeAlD
Zolmitriptan—HTR1A—brain—epilepsy syndrome	0.000419	0.00407	CbGeAlD
Zolmitriptan—MAOA—brain—epilepsy syndrome	0.000383	0.00372	CbGeAlD
Zolmitriptan—Eletriptan—CYP2C19—epilepsy syndrome	0.000379	0.0774	CrCbGaD
Zolmitriptan—Almotriptan—CYP2D6—epilepsy syndrome	0.00036	0.0736	CrCbGaD
Zolmitriptan—Melatonin—CYP2C19—epilepsy syndrome	0.000328	0.0671	CrCbGaD
Zolmitriptan—Eletriptan—CYP2D6—epilepsy syndrome	0.000281	0.0573	CrCbGaD
Zolmitriptan—Sumatriptan—ABCB1—epilepsy syndrome	0.000248	0.0506	CrCbGaD
Zolmitriptan—Eletriptan—ABCB1—epilepsy syndrome	0.0002	0.041	CrCbGaD
Zolmitriptan—Urethral disorder—Topiramate—epilepsy syndrome	5.8e-05	0.000155	CcSEcCtD
Zolmitriptan—Pruritus—Oxcarbazepine—epilepsy syndrome	5.79e-05	0.000154	CcSEcCtD
Zolmitriptan—Convulsion—Pregabalin—epilepsy syndrome	5.78e-05	0.000154	CcSEcCtD
Zolmitriptan—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.78e-05	0.000154	CcSEcCtD
Zolmitriptan—Headache—Vigabatrin—epilepsy syndrome	5.77e-05	0.000154	CcSEcCtD
Zolmitriptan—Hypertension—Pregabalin—epilepsy syndrome	5.76e-05	0.000154	CcSEcCtD
Zolmitriptan—Vomiting—Diazepam—epilepsy syndrome	5.76e-05	0.000154	CcSEcCtD
Zolmitriptan—Anorexia—Valproic Acid—epilepsy syndrome	5.74e-05	0.000153	CcSEcCtD
Zolmitriptan—Tremor—Gabapentin—epilepsy syndrome	5.74e-05	0.000153	CcSEcCtD
Zolmitriptan—Rash—Diazepam—epilepsy syndrome	5.72e-05	0.000152	CcSEcCtD
Zolmitriptan—Dermatitis—Diazepam—epilepsy syndrome	5.71e-05	0.000152	CcSEcCtD
Zolmitriptan—Myalgia—Pregabalin—epilepsy syndrome	5.68e-05	0.000151	CcSEcCtD
Zolmitriptan—Arthralgia—Pregabalin—epilepsy syndrome	5.68e-05	0.000151	CcSEcCtD
Zolmitriptan—Chest pain—Pregabalin—epilepsy syndrome	5.68e-05	0.000151	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.68e-05	0.000151	CcSEcCtD
Zolmitriptan—Dizziness—Zonisamide—epilepsy syndrome	5.68e-05	0.000151	CcSEcCtD
Zolmitriptan—Headache—Diazepam—epilepsy syndrome	5.68e-05	0.000151	CcSEcCtD
Zolmitriptan—Anxiety—Pregabalin—epilepsy syndrome	5.66e-05	0.000151	CcSEcCtD
Zolmitriptan—Diarrhoea—Clonazepam—epilepsy syndrome	5.66e-05	0.000151	CcSEcCtD
Zolmitriptan—Asthenia—Carbamazepine—epilepsy syndrome	5.63e-05	0.00015	CcSEcCtD
Zolmitriptan—Agitation—Gabapentin—epilepsy syndrome	5.63e-05	0.00015	CcSEcCtD
Zolmitriptan—Diarrhoea—Phenytoin—epilepsy syndrome	5.62e-05	0.00015	CcSEcCtD
Zolmitriptan—Discomfort—Pregabalin—epilepsy syndrome	5.62e-05	0.00015	CcSEcCtD
Zolmitriptan—Nausea—Fosphenytoin—epilepsy syndrome	5.61e-05	0.000149	CcSEcCtD
Zolmitriptan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.6e-05	0.000149	CcSEcCtD
Zolmitriptan—Angioedema—Gabapentin—epilepsy syndrome	5.59e-05	0.000149	CcSEcCtD
Zolmitriptan—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.59e-05	0.000149	CcSEcCtD
Zolmitriptan—Vomiting—Felbamate—epilepsy syndrome	5.58e-05	0.000149	CcSEcCtD
Zolmitriptan—Dry mouth—Pregabalin—epilepsy syndrome	5.56e-05	0.000148	CcSEcCtD
Zolmitriptan—Pruritus—Carbamazepine—epilepsy syndrome	5.55e-05	0.000148	CcSEcCtD
Zolmitriptan—Rash—Felbamate—epilepsy syndrome	5.53e-05	0.000147	CcSEcCtD
Zolmitriptan—Dermatitis—Felbamate—epilepsy syndrome	5.53e-05	0.000147	CcSEcCtD
Zolmitriptan—Malaise—Gabapentin—epilepsy syndrome	5.52e-05	0.000147	CcSEcCtD
Zolmitriptan—Tinnitus—Topiramate—epilepsy syndrome	5.52e-05	0.000147	CcSEcCtD
Zolmitriptan—Vertigo—Gabapentin—epilepsy syndrome	5.5e-05	0.000147	CcSEcCtD
Zolmitriptan—Headache—Felbamate—epilepsy syndrome	5.5e-05	0.000146	CcSEcCtD
Zolmitriptan—Confusional state—Pregabalin—epilepsy syndrome	5.49e-05	0.000146	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.49e-05	0.000146	CcSEcCtD
Zolmitriptan—Cardiac disorder—Topiramate—epilepsy syndrome	5.49e-05	0.000146	CcSEcCtD
Zolmitriptan—Syncope—Gabapentin—epilepsy syndrome	5.49e-05	0.000146	CcSEcCtD
Zolmitriptan—Leukopenia—Gabapentin—epilepsy syndrome	5.48e-05	0.000146	CcSEcCtD
Zolmitriptan—Dizziness—Clonazepam—epilepsy syndrome	5.47e-05	0.000146	CcSEcCtD
Zolmitriptan—Nausea—Vigabatrin—epilepsy syndrome	5.47e-05	0.000146	CcSEcCtD
Zolmitriptan—Vomiting—Zonisamide—epilepsy syndrome	5.46e-05	0.000145	CcSEcCtD
Zolmitriptan—Insomnia—Valproic Acid—epilepsy syndrome	5.45e-05	0.000145	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.45e-05	0.000145	CcSEcCtD
Zolmitriptan—Oedema—Pregabalin—epilepsy syndrome	5.45e-05	0.000145	CcSEcCtD
Zolmitriptan—Asthenia—Lamotrigine—epilepsy syndrome	5.44e-05	0.000145	CcSEcCtD
Zolmitriptan—Dizziness—Phenytoin—epilepsy syndrome	5.44e-05	0.000145	CcSEcCtD
Zolmitriptan—Rash—Zonisamide—epilepsy syndrome	5.41e-05	0.000144	CcSEcCtD
Zolmitriptan—Infection—Pregabalin—epilepsy syndrome	5.41e-05	0.000144	CcSEcCtD
Zolmitriptan—Paraesthesia—Valproic Acid—epilepsy syndrome	5.41e-05	0.000144	CcSEcCtD
Zolmitriptan—Palpitations—Gabapentin—epilepsy syndrome	5.41e-05	0.000144	CcSEcCtD
Zolmitriptan—Dermatitis—Zonisamide—epilepsy syndrome	5.41e-05	0.000144	CcSEcCtD
Zolmitriptan—Dizziness—Oxcarbazepine—epilepsy syndrome	5.41e-05	0.000144	CcSEcCtD
Zolmitriptan—Nausea—Diazepam—epilepsy syndrome	5.38e-05	0.000143	CcSEcCtD
Zolmitriptan—Loss of consciousness—Gabapentin—epilepsy syndrome	5.38e-05	0.000143	CcSEcCtD
Zolmitriptan—Headache—Zonisamide—epilepsy syndrome	5.38e-05	0.000143	CcSEcCtD
Zolmitriptan—Dyspnoea—Valproic Acid—epilepsy syndrome	5.37e-05	0.000143	CcSEcCtD
Zolmitriptan—Diarrhoea—Carbamazepine—epilepsy syndrome	5.37e-05	0.000143	CcSEcCtD
Zolmitriptan—Angiopathy—Topiramate—epilepsy syndrome	5.37e-05	0.000143	CcSEcCtD
Zolmitriptan—Pruritus—Lamotrigine—epilepsy syndrome	5.37e-05	0.000143	CcSEcCtD
Zolmitriptan—Shock—Pregabalin—epilepsy syndrome	5.36e-05	0.000143	CcSEcCtD
Zolmitriptan—Somnolence—Valproic Acid—epilepsy syndrome	5.36e-05	0.000143	CcSEcCtD
Zolmitriptan—Immune system disorder—Topiramate—epilepsy syndrome	5.34e-05	0.000142	CcSEcCtD
Zolmitriptan—Nervous system disorder—Pregabalin—epilepsy syndrome	5.34e-05	0.000142	CcSEcCtD
Zolmitriptan—Cough—Gabapentin—epilepsy syndrome	5.34e-05	0.000142	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.33e-05	0.000142	CcSEcCtD
Zolmitriptan—Tachycardia—Pregabalin—epilepsy syndrome	5.32e-05	0.000142	CcSEcCtD
Zolmitriptan—Chills—Topiramate—epilepsy syndrome	5.31e-05	0.000141	CcSEcCtD
Zolmitriptan—Dyspepsia—Valproic Acid—epilepsy syndrome	5.3e-05	0.000141	CcSEcCtD
Zolmitriptan—Convulsion—Gabapentin—epilepsy syndrome	5.3e-05	0.000141	CcSEcCtD
Zolmitriptan—Skin disorder—Pregabalin—epilepsy syndrome	5.29e-05	0.000141	CcSEcCtD
Zolmitriptan—Hypertension—Gabapentin—epilepsy syndrome	5.29e-05	0.000141	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.27e-05	0.00014	CcSEcCtD
Zolmitriptan—Vomiting—Clonazepam—epilepsy syndrome	5.26e-05	0.00014	CcSEcCtD
Zolmitriptan—Decreased appetite—Valproic Acid—epilepsy syndrome	5.24e-05	0.00014	CcSEcCtD
Zolmitriptan—Vomiting—Phenytoin—epilepsy syndrome	5.23e-05	0.000139	CcSEcCtD
Zolmitriptan—Rash—Clonazepam—epilepsy syndrome	5.22e-05	0.000139	CcSEcCtD
Zolmitriptan—Dermatitis—Clonazepam—epilepsy syndrome	5.21e-05	0.000139	CcSEcCtD
Zolmitriptan—Chest pain—Gabapentin—epilepsy syndrome	5.21e-05	0.000139	CcSEcCtD
Zolmitriptan—Myalgia—Gabapentin—epilepsy syndrome	5.21e-05	0.000139	CcSEcCtD
Zolmitriptan—Arthralgia—Gabapentin—epilepsy syndrome	5.21e-05	0.000139	CcSEcCtD
Zolmitriptan—Nausea—Felbamate—epilepsy syndrome	5.21e-05	0.000139	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.2e-05	0.000139	CcSEcCtD
Zolmitriptan—Vomiting—Oxcarbazepine—epilepsy syndrome	5.2e-05	0.000139	CcSEcCtD
Zolmitriptan—Anxiety—Gabapentin—epilepsy syndrome	5.19e-05	0.000138	CcSEcCtD
Zolmitriptan—Anorexia—Pregabalin—epilepsy syndrome	5.19e-05	0.000138	CcSEcCtD
Zolmitriptan—Dizziness—Carbamazepine—epilepsy syndrome	5.19e-05	0.000138	CcSEcCtD
Zolmitriptan—Diarrhoea—Lamotrigine—epilepsy syndrome	5.19e-05	0.000138	CcSEcCtD
Zolmitriptan—Headache—Clonazepam—epilepsy syndrome	5.18e-05	0.000138	CcSEcCtD
Zolmitriptan—Rash—Phenytoin—epilepsy syndrome	5.18e-05	0.000138	CcSEcCtD
Zolmitriptan—Dermatitis—Phenytoin—epilepsy syndrome	5.18e-05	0.000138	CcSEcCtD
Zolmitriptan—Rash—Oxcarbazepine—epilepsy syndrome	5.16e-05	0.000137	CcSEcCtD
Zolmitriptan—Pain—Valproic Acid—epilepsy syndrome	5.15e-05	0.000137	CcSEcCtD
Zolmitriptan—Constipation—Valproic Acid—epilepsy syndrome	5.15e-05	0.000137	CcSEcCtD
Zolmitriptan—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.15e-05	0.000137	CcSEcCtD
Zolmitriptan—Headache—Phenytoin—epilepsy syndrome	5.15e-05	0.000137	CcSEcCtD
Zolmitriptan—Erythema—Topiramate—epilepsy syndrome	5.15e-05	0.000137	CcSEcCtD
Zolmitriptan—Discomfort—Gabapentin—epilepsy syndrome	5.15e-05	0.000137	CcSEcCtD
Zolmitriptan—Headache—Oxcarbazepine—epilepsy syndrome	5.12e-05	0.000136	CcSEcCtD
Zolmitriptan—Nausea—Zonisamide—epilepsy syndrome	5.1e-05	0.000136	CcSEcCtD
Zolmitriptan—Dry mouth—Gabapentin—epilepsy syndrome	5.1e-05	0.000136	CcSEcCtD
Zolmitriptan—Tension—Topiramate—epilepsy syndrome	5.05e-05	0.000135	CcSEcCtD
Zolmitriptan—Dysgeusia—Topiramate—epilepsy syndrome	5.04e-05	0.000134	CcSEcCtD
Zolmitriptan—Confusional state—Gabapentin—epilepsy syndrome	5.04e-05	0.000134	CcSEcCtD
Zolmitriptan—Dizziness—Lamotrigine—epilepsy syndrome	5.02e-05	0.000134	CcSEcCtD
Zolmitriptan—Nervousness—Topiramate—epilepsy syndrome	5e-05	0.000133	CcSEcCtD
Zolmitriptan—Oedema—Gabapentin—epilepsy syndrome	5e-05	0.000133	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Gabapentin—epilepsy syndrome	5e-05	0.000133	CcSEcCtD
Zolmitriptan—Vomiting—Carbamazepine—epilepsy syndrome	4.99e-05	0.000133	CcSEcCtD
Zolmitriptan—Back pain—Topiramate—epilepsy syndrome	4.98e-05	0.000133	CcSEcCtD
Zolmitriptan—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.97e-05	0.000132	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.96e-05	0.000132	CcSEcCtD
Zolmitriptan—Infection—Gabapentin—epilepsy syndrome	4.96e-05	0.000132	CcSEcCtD
Zolmitriptan—Muscle spasms—Topiramate—epilepsy syndrome	4.95e-05	0.000132	CcSEcCtD
Zolmitriptan—Rash—Carbamazepine—epilepsy syndrome	4.95e-05	0.000132	CcSEcCtD
Zolmitriptan—Dermatitis—Carbamazepine—epilepsy syndrome	4.94e-05	0.000132	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.93e-05	0.000131	CcSEcCtD
Zolmitriptan—Insomnia—Pregabalin—epilepsy syndrome	4.93e-05	0.000131	CcSEcCtD
Zolmitriptan—Nausea—Clonazepam—epilepsy syndrome	4.92e-05	0.000131	CcSEcCtD
Zolmitriptan—Headache—Carbamazepine—epilepsy syndrome	4.92e-05	0.000131	CcSEcCtD
Zolmitriptan—Shock—Gabapentin—epilepsy syndrome	4.92e-05	0.000131	CcSEcCtD
Zolmitriptan—Nervous system disorder—Gabapentin—epilepsy syndrome	4.9e-05	0.000131	CcSEcCtD
Zolmitriptan—Paraesthesia—Pregabalin—epilepsy syndrome	4.89e-05	0.00013	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.89e-05	0.00013	CcSEcCtD
Zolmitriptan—Nausea—Phenytoin—epilepsy syndrome	4.88e-05	0.00013	CcSEcCtD
Zolmitriptan—Tachycardia—Gabapentin—epilepsy syndrome	4.88e-05	0.00013	CcSEcCtD
Zolmitriptan—Dyspnoea—Pregabalin—epilepsy syndrome	4.86e-05	0.000129	CcSEcCtD
Zolmitriptan—Nausea—Oxcarbazepine—epilepsy syndrome	4.86e-05	0.000129	CcSEcCtD
Zolmitriptan—Skin disorder—Gabapentin—epilepsy syndrome	4.85e-05	0.000129	CcSEcCtD
Zolmitriptan—Somnolence—Pregabalin—epilepsy syndrome	4.84e-05	0.000129	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.83e-05	0.000129	CcSEcCtD
Zolmitriptan—Tremor—Topiramate—epilepsy syndrome	4.83e-05	0.000129	CcSEcCtD
Zolmitriptan—Vomiting—Lamotrigine—epilepsy syndrome	4.82e-05	0.000128	CcSEcCtD
Zolmitriptan—Urticaria—Valproic Acid—epilepsy syndrome	4.79e-05	0.000128	CcSEcCtD
Zolmitriptan—Rash—Lamotrigine—epilepsy syndrome	4.78e-05	0.000127	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Topiramate—epilepsy syndrome	4.78e-05	0.000127	CcSEcCtD
Zolmitriptan—Dermatitis—Lamotrigine—epilepsy syndrome	4.78e-05	0.000127	CcSEcCtD
Zolmitriptan—Abdominal pain—Valproic Acid—epilepsy syndrome	4.76e-05	0.000127	CcSEcCtD
Zolmitriptan—Body temperature increased—Valproic Acid—epilepsy syndrome	4.76e-05	0.000127	CcSEcCtD
Zolmitriptan—Anorexia—Gabapentin—epilepsy syndrome	4.76e-05	0.000127	CcSEcCtD
Zolmitriptan—Headache—Lamotrigine—epilepsy syndrome	4.75e-05	0.000127	CcSEcCtD
Zolmitriptan—Decreased appetite—Pregabalin—epilepsy syndrome	4.74e-05	0.000126	CcSEcCtD
Zolmitriptan—Agitation—Topiramate—epilepsy syndrome	4.73e-05	0.000126	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.7e-05	0.000125	CcSEcCtD
Zolmitriptan—Nausea—Carbamazepine—epilepsy syndrome	4.66e-05	0.000124	CcSEcCtD
Zolmitriptan—Pain—Pregabalin—epilepsy syndrome	4.66e-05	0.000124	CcSEcCtD
Zolmitriptan—Constipation—Pregabalin—epilepsy syndrome	4.66e-05	0.000124	CcSEcCtD
Zolmitriptan—Malaise—Topiramate—epilepsy syndrome	4.64e-05	0.000124	CcSEcCtD
Zolmitriptan—Vertigo—Topiramate—epilepsy syndrome	4.63e-05	0.000123	CcSEcCtD
Zolmitriptan—Syncope—Topiramate—epilepsy syndrome	4.62e-05	0.000123	CcSEcCtD
Zolmitriptan—Leukopenia—Topiramate—epilepsy syndrome	4.61e-05	0.000123	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.55e-05	0.000121	CcSEcCtD
Zolmitriptan—Palpitations—Topiramate—epilepsy syndrome	4.55e-05	0.000121	CcSEcCtD
Zolmitriptan—Loss of consciousness—Topiramate—epilepsy syndrome	4.53e-05	0.000121	CcSEcCtD
Zolmitriptan—Insomnia—Gabapentin—epilepsy syndrome	4.52e-05	0.00012	CcSEcCtD
Zolmitriptan—Nausea—Lamotrigine—epilepsy syndrome	4.5e-05	0.00012	CcSEcCtD
Zolmitriptan—Cough—Topiramate—epilepsy syndrome	4.49e-05	0.00012	CcSEcCtD
Zolmitriptan—Feeling abnormal—Pregabalin—epilepsy syndrome	4.49e-05	0.00012	CcSEcCtD
Zolmitriptan—Paraesthesia—Gabapentin—epilepsy syndrome	4.49e-05	0.00012	CcSEcCtD
Zolmitriptan—Convulsion—Topiramate—epilepsy syndrome	4.46e-05	0.000119	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.46e-05	0.000119	CcSEcCtD
Zolmitriptan—Dyspnoea—Gabapentin—epilepsy syndrome	4.45e-05	0.000119	CcSEcCtD
Zolmitriptan—Hypertension—Topiramate—epilepsy syndrome	4.45e-05	0.000118	CcSEcCtD
Zolmitriptan—Somnolence—Gabapentin—epilepsy syndrome	4.44e-05	0.000118	CcSEcCtD
Zolmitriptan—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.44e-05	0.000118	CcSEcCtD
Zolmitriptan—Dyspepsia—Gabapentin—epilepsy syndrome	4.4e-05	0.000117	CcSEcCtD
Zolmitriptan—Arthralgia—Topiramate—epilepsy syndrome	4.38e-05	0.000117	CcSEcCtD
Zolmitriptan—Myalgia—Topiramate—epilepsy syndrome	4.38e-05	0.000117	CcSEcCtD
Zolmitriptan—Chest pain—Topiramate—epilepsy syndrome	4.38e-05	0.000117	CcSEcCtD
Zolmitriptan—Anxiety—Topiramate—epilepsy syndrome	4.37e-05	0.000116	CcSEcCtD
Zolmitriptan—Decreased appetite—Gabapentin—epilepsy syndrome	4.34e-05	0.000116	CcSEcCtD
Zolmitriptan—Discomfort—Topiramate—epilepsy syndrome	4.33e-05	0.000115	CcSEcCtD
Zolmitriptan—Urticaria—Pregabalin—epilepsy syndrome	4.33e-05	0.000115	CcSEcCtD
Zolmitriptan—Asthenia—Valproic Acid—epilepsy syndrome	4.32e-05	0.000115	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.31e-05	0.000115	CcSEcCtD
Zolmitriptan—Body temperature increased—Pregabalin—epilepsy syndrome	4.31e-05	0.000115	CcSEcCtD
Zolmitriptan—Abdominal pain—Pregabalin—epilepsy syndrome	4.31e-05	0.000115	CcSEcCtD
Zolmitriptan—Dry mouth—Topiramate—epilepsy syndrome	4.29e-05	0.000114	CcSEcCtD
Zolmitriptan—Constipation—Gabapentin—epilepsy syndrome	4.27e-05	0.000114	CcSEcCtD
Zolmitriptan—Pain—Gabapentin—epilepsy syndrome	4.27e-05	0.000114	CcSEcCtD
Zolmitriptan—Pruritus—Valproic Acid—epilepsy syndrome	4.26e-05	0.000114	CcSEcCtD
Zolmitriptan—Confusional state—Topiramate—epilepsy syndrome	4.24e-05	0.000113	CcSEcCtD
Zolmitriptan—Oedema—Topiramate—epilepsy syndrome	4.2e-05	0.000112	CcSEcCtD
Zolmitriptan—Infection—Topiramate—epilepsy syndrome	4.18e-05	0.000111	CcSEcCtD
Zolmitriptan—Shock—Topiramate—epilepsy syndrome	4.14e-05	0.00011	CcSEcCtD
Zolmitriptan—Diarrhoea—Valproic Acid—epilepsy syndrome	4.12e-05	0.00011	CcSEcCtD
Zolmitriptan—Nervous system disorder—Topiramate—epilepsy syndrome	4.12e-05	0.00011	CcSEcCtD
Zolmitriptan—Feeling abnormal—Gabapentin—epilepsy syndrome	4.12e-05	0.00011	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Topiramate—epilepsy syndrome	4.12e-05	0.00011	CcSEcCtD
Zolmitriptan—Tachycardia—Topiramate—epilepsy syndrome	4.1e-05	0.000109	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.09e-05	0.000109	CcSEcCtD
Zolmitriptan—Skin disorder—Topiramate—epilepsy syndrome	4.08e-05	0.000109	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Topiramate—epilepsy syndrome	4.06e-05	0.000108	CcSEcCtD
Zolmitriptan—Hypersensitivity—Pregabalin—epilepsy syndrome	4.01e-05	0.000107	CcSEcCtD
Zolmitriptan—Anorexia—Topiramate—epilepsy syndrome	4.01e-05	0.000107	CcSEcCtD
Zolmitriptan—Dizziness—Valproic Acid—epilepsy syndrome	3.99e-05	0.000106	CcSEcCtD
Zolmitriptan—Urticaria—Gabapentin—epilepsy syndrome	3.97e-05	0.000106	CcSEcCtD
Zolmitriptan—Abdominal pain—Gabapentin—epilepsy syndrome	3.95e-05	0.000105	CcSEcCtD
Zolmitriptan—Body temperature increased—Gabapentin—epilepsy syndrome	3.95e-05	0.000105	CcSEcCtD
Zolmitriptan—Asthenia—Pregabalin—epilepsy syndrome	3.91e-05	0.000104	CcSEcCtD
Zolmitriptan—Pruritus—Pregabalin—epilepsy syndrome	3.85e-05	0.000103	CcSEcCtD
Zolmitriptan—Vomiting—Valproic Acid—epilepsy syndrome	3.83e-05	0.000102	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.83e-05	0.000102	CcSEcCtD
Zolmitriptan—Insomnia—Topiramate—epilepsy syndrome	3.8e-05	0.000101	CcSEcCtD
Zolmitriptan—Rash—Valproic Acid—epilepsy syndrome	3.8e-05	0.000101	CcSEcCtD
Zolmitriptan—Dermatitis—Valproic Acid—epilepsy syndrome	3.8e-05	0.000101	CcSEcCtD
Zolmitriptan—Headache—Valproic Acid—epilepsy syndrome	3.78e-05	0.000101	CcSEcCtD
Zolmitriptan—Paraesthesia—Topiramate—epilepsy syndrome	3.77e-05	0.000101	CcSEcCtD
Zolmitriptan—Dyspnoea—Topiramate—epilepsy syndrome	3.75e-05	9.98e-05	CcSEcCtD
Zolmitriptan—Somnolence—Topiramate—epilepsy syndrome	3.74e-05	9.96e-05	CcSEcCtD
Zolmitriptan—Diarrhoea—Pregabalin—epilepsy syndrome	3.73e-05	9.93e-05	CcSEcCtD
Zolmitriptan—Dyspepsia—Topiramate—epilepsy syndrome	3.7e-05	9.86e-05	CcSEcCtD
Zolmitriptan—Hypersensitivity—Gabapentin—epilepsy syndrome	3.68e-05	9.81e-05	CcSEcCtD
Zolmitriptan—Decreased appetite—Topiramate—epilepsy syndrome	3.65e-05	9.73e-05	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.63e-05	9.67e-05	CcSEcCtD
Zolmitriptan—Dizziness—Pregabalin—epilepsy syndrome	3.6e-05	9.6e-05	CcSEcCtD
Zolmitriptan—Pain—Topiramate—epilepsy syndrome	3.59e-05	9.58e-05	CcSEcCtD
Zolmitriptan—Constipation—Topiramate—epilepsy syndrome	3.59e-05	9.58e-05	CcSEcCtD
Zolmitriptan—Asthenia—Gabapentin—epilepsy syndrome	3.58e-05	9.55e-05	CcSEcCtD
Zolmitriptan—Nausea—Valproic Acid—epilepsy syndrome	3.58e-05	9.54e-05	CcSEcCtD
Zolmitriptan—Pruritus—Gabapentin—epilepsy syndrome	3.53e-05	9.42e-05	CcSEcCtD
Zolmitriptan—Vomiting—Pregabalin—epilepsy syndrome	3.46e-05	9.23e-05	CcSEcCtD
Zolmitriptan—Feeling abnormal—Topiramate—epilepsy syndrome	3.46e-05	9.23e-05	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.44e-05	9.16e-05	CcSEcCtD
Zolmitriptan—Rash—Pregabalin—epilepsy syndrome	3.44e-05	9.15e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Pregabalin—epilepsy syndrome	3.43e-05	9.14e-05	CcSEcCtD
Zolmitriptan—Diarrhoea—Gabapentin—epilepsy syndrome	3.42e-05	9.11e-05	CcSEcCtD
Zolmitriptan—Headache—Pregabalin—epilepsy syndrome	3.41e-05	9.09e-05	CcSEcCtD
Zolmitriptan—Urticaria—Topiramate—epilepsy syndrome	3.34e-05	8.9e-05	CcSEcCtD
Zolmitriptan—Body temperature increased—Topiramate—epilepsy syndrome	3.32e-05	8.85e-05	CcSEcCtD
Zolmitriptan—Abdominal pain—Topiramate—epilepsy syndrome	3.32e-05	8.85e-05	CcSEcCtD
Zolmitriptan—Dizziness—Gabapentin—epilepsy syndrome	3.3e-05	8.8e-05	CcSEcCtD
Zolmitriptan—Nausea—Pregabalin—epilepsy syndrome	3.24e-05	8.62e-05	CcSEcCtD
Zolmitriptan—Vomiting—Gabapentin—epilepsy syndrome	3.18e-05	8.46e-05	CcSEcCtD
Zolmitriptan—Rash—Gabapentin—epilepsy syndrome	3.15e-05	8.39e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Gabapentin—epilepsy syndrome	3.15e-05	8.38e-05	CcSEcCtD
Zolmitriptan—Headache—Gabapentin—epilepsy syndrome	3.13e-05	8.34e-05	CcSEcCtD
Zolmitriptan—Hypersensitivity—Topiramate—epilepsy syndrome	3.1e-05	8.25e-05	CcSEcCtD
Zolmitriptan—Asthenia—Topiramate—epilepsy syndrome	3.02e-05	8.03e-05	CcSEcCtD
Zolmitriptan—Pruritus—Topiramate—epilepsy syndrome	2.97e-05	7.92e-05	CcSEcCtD
Zolmitriptan—Nausea—Gabapentin—epilepsy syndrome	2.97e-05	7.91e-05	CcSEcCtD
Zolmitriptan—Diarrhoea—Topiramate—epilepsy syndrome	2.88e-05	7.66e-05	CcSEcCtD
Zolmitriptan—Dizziness—Topiramate—epilepsy syndrome	2.78e-05	7.41e-05	CcSEcCtD
Zolmitriptan—Vomiting—Topiramate—epilepsy syndrome	2.67e-05	7.12e-05	CcSEcCtD
Zolmitriptan—Rash—Topiramate—epilepsy syndrome	2.65e-05	7.06e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Topiramate—epilepsy syndrome	2.65e-05	7.05e-05	CcSEcCtD
Zolmitriptan—Headache—Topiramate—epilepsy syndrome	2.63e-05	7.02e-05	CcSEcCtD
Zolmitriptan—Nausea—Topiramate—epilepsy syndrome	2.5e-05	6.65e-05	CcSEcCtD
Zolmitriptan—HTR1A—Signaling by GPCR—CDC42—epilepsy syndrome	1.53e-05	9.23e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HTR2A—epilepsy syndrome	1.52e-05	9.21e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GABBR1—epilepsy syndrome	1.52e-05	9.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NTRK2—epilepsy syndrome	1.51e-05	9.14e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCR2—epilepsy syndrome	1.51e-05	9.14e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SST—epilepsy syndrome	1.51e-05	9.14e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ADRA2A—epilepsy syndrome	1.51e-05	9.14e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—SLC2A1—epilepsy syndrome	1.51e-05	9.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PLAT—epilepsy syndrome	1.5e-05	9.1e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—DUSP6—epilepsy syndrome	1.5e-05	9.06e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PLCB1—epilepsy syndrome	1.49e-05	9.01e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—TH—epilepsy syndrome	1.48e-05	8.98e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ADRA2A—epilepsy syndrome	1.48e-05	8.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AVP—epilepsy syndrome	1.48e-05	8.94e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PLAT—epilepsy syndrome	1.47e-05	8.91e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HRH3—epilepsy syndrome	1.46e-05	8.81e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL12—epilepsy syndrome	1.45e-05	8.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BDKRB2—epilepsy syndrome	1.45e-05	8.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—POMC—epilepsy syndrome	1.45e-05	8.77e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TSC2—epilepsy syndrome	1.45e-05	8.75e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PRKCB—epilepsy syndrome	1.44e-05	8.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AGT—epilepsy syndrome	1.44e-05	8.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6ST—epilepsy syndrome	1.44e-05	8.7e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.44e-05	8.7e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.44e-05	8.7e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.44e-05	8.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—OPRM1—epilepsy syndrome	1.43e-05	8.67e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CNR1—epilepsy syndrome	1.42e-05	8.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JUNB—epilepsy syndrome	1.42e-05	8.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL12—epilepsy syndrome	1.42e-05	8.6e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.42e-05	8.6e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PLCB1—epilepsy syndrome	1.42e-05	8.59e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—POMC—epilepsy syndrome	1.42e-05	8.58e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—APOE—epilepsy syndrome	1.42e-05	8.56e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PRKCB—epilepsy syndrome	1.41e-05	8.56e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6ST—epilepsy syndrome	1.41e-05	8.52e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JUNB—epilepsy syndrome	1.4e-05	8.44e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CNR1—epilepsy syndrome	1.4e-05	8.44e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HTR7—epilepsy syndrome	1.39e-05	8.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PLCB1—epilepsy syndrome	1.39e-05	8.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KDR—epilepsy syndrome	1.39e-05	8.39e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.39e-05	8.38e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.38e-05	8.37e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HTR7—epilepsy syndrome	1.36e-05	8.23e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR3—epilepsy syndrome	1.35e-05	8.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.35e-05	8.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HBEGF—epilepsy syndrome	1.35e-05	8.16e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.34e-05	8.09e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.34e-05	8.09e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PRKCB—epilepsy syndrome	1.33e-05	8.07e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6ST—epilepsy syndrome	1.33e-05	8.04e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT3—epilepsy syndrome	1.32e-05	8.01e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HBEGF—epilepsy syndrome	1.32e-05	7.99e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.32e-05	7.98e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NPY—epilepsy syndrome	1.32e-05	7.98e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—POMC—epilepsy syndrome	1.32e-05	7.96e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.31e-05	7.91e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT3—epilepsy syndrome	1.3e-05	7.84e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ADAM10—epilepsy syndrome	1.29e-05	7.83e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—POMC—epilepsy syndrome	1.29e-05	7.79e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCL2—epilepsy syndrome	1.29e-05	7.79e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AGT—epilepsy syndrome	1.28e-05	7.77e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HSPB1—epilepsy syndrome	1.27e-05	7.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CRH—epilepsy syndrome	1.27e-05	7.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—OXT—epilepsy syndrome	1.27e-05	7.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL3—epilepsy syndrome	1.27e-05	7.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL2—epilepsy syndrome	1.27e-05	7.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ADAM10—epilepsy syndrome	1.27e-05	7.66e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCL2—epilepsy syndrome	1.26e-05	7.63e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.26e-05	7.61e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCR5—epilepsy syndrome	1.26e-05	7.6e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—HMOX1—epilepsy syndrome	1.24e-05	7.49e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.23e-05	7.44e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	1.22e-05	7.4e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—S100B—epilepsy syndrome	1.22e-05	7.4e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CAT—epilepsy syndrome	1.22e-05	7.39e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—POMC—epilepsy syndrome	1.22e-05	7.35e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SOCS3—epilepsy syndrome	1.21e-05	7.33e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDC42—epilepsy syndrome	1.21e-05	7.31e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—S100B—epilepsy syndrome	1.2e-05	7.25e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALAD—epilepsy syndrome	1.19e-05	7.21e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NT5E—epilepsy syndrome	1.19e-05	7.21e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCL2—epilepsy syndrome	1.19e-05	7.2e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ABCB1—epilepsy syndrome	1.19e-05	7.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.19e-05	7.18e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SOCS3—epilepsy syndrome	1.19e-05	7.17e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TSC1—epilepsy syndrome	1.18e-05	7.16e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTK2B—epilepsy syndrome	1.18e-05	7.16e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDC42—epilepsy syndrome	1.18e-05	7.16e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AVP—epilepsy syndrome	1.17e-05	7.08e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AGT—epilepsy syndrome	1.17e-05	7.05e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NTRK2—epilepsy syndrome	1.15e-05	6.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SST—epilepsy syndrome	1.15e-05	6.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR2—epilepsy syndrome	1.15e-05	6.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AVP—epilepsy syndrome	1.15e-05	6.93e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—DUSP6—epilepsy syndrome	1.14e-05	6.9e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	1.14e-05	6.88e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	1.14e-05	6.88e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADRA2A—epilepsy syndrome	1.13e-05	6.82e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PLAT—epilepsy syndrome	1.12e-05	6.79e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	1.11e-05	6.73e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HES1—epilepsy syndrome	1.11e-05	6.69e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GPX1—epilepsy syndrome	1.11e-05	6.69e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ADSL—epilepsy syndrome	1.09e-05	6.6e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HES1—epilepsy syndrome	1.08e-05	6.55e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.08e-05	6.55e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL12—epilepsy syndrome	1.08e-05	6.55e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—POMC—epilepsy syndrome	1.08e-05	6.54e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.08e-05	6.52e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FYN—epilepsy syndrome	1.08e-05	6.51e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—FGF2—epilepsy syndrome	1.08e-05	6.5e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.07e-05	6.49e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—H2AFX—epilepsy syndrome	1.07e-05	6.48e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MEF2C—epilepsy syndrome	1.07e-05	6.47e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.07e-05	6.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JUNB—epilepsy syndrome	1.06e-05	6.43e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CNR1—epilepsy syndrome	1.06e-05	6.43e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PLCB1—epilepsy syndrome	1.06e-05	6.4e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FYN—epilepsy syndrome	1.05e-05	6.37e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.05e-05	6.35e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.05e-05	6.35e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.05e-05	6.34e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HTR7—epilepsy syndrome	1.04e-05	6.27e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—YWHAZ—epilepsy syndrome	1.03e-05	6.26e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NGF—epilepsy syndrome	1.02e-05	6.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.01e-05	6.13e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HBEGF—epilepsy syndrome	1.01e-05	6.09e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NGF—epilepsy syndrome	1e-05	6.06e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RELA—epilepsy syndrome	9.98e-06	6.04e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCR5—epilepsy syndrome	9.95e-06	6.02e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	9.88e-06	5.98e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	9.82e-06	5.94e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	9.82e-06	5.94e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MTOR—epilepsy syndrome	9.79e-06	5.92e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCR5—epilepsy syndrome	9.74e-06	5.89e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HTR2A—epilepsy syndrome	9.74e-06	5.89e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AGT—epilepsy syndrome	9.69e-06	5.86e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	9.65e-06	5.84e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	9.61e-06	5.81e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HTR2A—epilepsy syndrome	9.53e-06	5.77e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AQP1—epilepsy syndrome	9.53e-06	5.77e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—APOE—epilepsy syndrome	9.5e-06	5.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TSC2—epilepsy syndrome	9.25e-06	5.59e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AGT—epilepsy syndrome	9.24e-06	5.59e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	9.15e-06	5.54e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	9.12e-06	5.52e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT1—epilepsy syndrome	9.09e-06	5.5e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TSC2—epilepsy syndrome	9.06e-06	5.48e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOE—epilepsy syndrome	9.05e-06	5.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AGT—epilepsy syndrome	9.04e-06	5.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	9.04e-06	5.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	9.01e-06	5.45e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CASP3—epilepsy syndrome	9e-06	5.44e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KDR—epilepsy syndrome	8.87e-06	5.36e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOE—epilepsy syndrome	8.86e-06	5.36e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—JUN—epilepsy syndrome	8.74e-06	5.29e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	8.73e-06	5.28e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KDR—epilepsy syndrome	8.68e-06	5.25e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	8.62e-06	5.21e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	8.62e-06	5.21e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PRKCB—epilepsy syndrome	8.53e-06	5.16e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—epilepsy syndrome	8.51e-06	5.15e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6ST—epilepsy syndrome	8.5e-06	5.14e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PRKCB—epilepsy syndrome	8.36e-06	5.05e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6ST—epilepsy syndrome	8.32e-06	5.03e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	8.25e-06	4.99e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—epilepsy syndrome	8.25e-06	4.99e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—POMC—epilepsy syndrome	8.16e-06	4.94e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	8.03e-06	4.86e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	8.02e-06	4.85e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	8e-06	4.84e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	7.98e-06	4.83e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.87e-06	4.76e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SRC—epilepsy syndrome	7.84e-06	4.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—POMC—epilepsy syndrome	7.77e-06	4.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	7.71e-06	4.67e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—epilepsy syndrome	7.64e-06	4.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	7.63e-06	4.61e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	7.61e-06	4.6e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL2—epilepsy syndrome	7.61e-06	4.6e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	7.45e-06	4.51e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALB—epilepsy syndrome	7.44e-06	4.5e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	7.42e-06	4.49e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	7.26e-06	4.39e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	7.03e-06	4.25e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	6.9e-06	4.17e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	6.89e-06	4.17e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	6.88e-06	4.16e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	6.85e-06	4.14e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	6.81e-06	4.12e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.76e-06	4.09e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	6.75e-06	4.08e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	6.73e-06	4.07e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	6.61e-06	4e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—epilepsy syndrome	6.51e-06	3.94e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	6.38e-06	3.86e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	6.37e-06	3.85e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	6.34e-06	3.84e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	6.26e-06	3.79e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	6.25e-06	3.78e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.16e-06	3.73e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	6.14e-06	3.72e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	6.13e-06	3.71e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	5.85e-06	3.54e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—BCHE—epilepsy syndrome	5.82e-06	3.52e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	5.81e-06	3.51e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	5.8e-06	3.51e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	5.76e-06	3.48e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.69e-06	3.44e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	5.67e-06	3.43e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	5.64e-06	3.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	5.59e-06	3.38e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	5.55e-06	3.36e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	5.49e-06	3.32e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	5.47e-06	3.31e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TH—epilepsy syndrome	5.47e-06	3.31e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	5.44e-06	3.29e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.39e-06	3.26e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	5.33e-06	3.22e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	5.28e-06	3.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	5.17e-06	3.12e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	5.13e-06	3.1e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	5.02e-06	3.03e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	4.91e-06	2.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	4.88e-06	2.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—epilepsy syndrome	4.87e-06	2.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	4.78e-06	2.89e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	4.76e-06	2.88e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	4.67e-06	2.82e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	4.57e-06	2.76e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CAT—epilepsy syndrome	4.51e-06	2.73e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	4.39e-06	2.65e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.33e-06	2.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	4.29e-06	2.6e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	4.17e-06	2.52e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GPX1—epilepsy syndrome	4.08e-06	2.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	4.06e-06	2.45e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.94e-06	2.38e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	3.74e-06	2.26e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	3.64e-06	2.2e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AGT—epilepsy syndrome	3.57e-06	2.16e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOE—epilepsy syndrome	3.5e-06	2.12e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—epilepsy syndrome	3.27e-06	1.98e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	3.12e-06	1.89e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	3.05e-06	1.85e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—POMC—epilepsy syndrome	3.01e-06	1.82e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.74e-06	1.66e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2.4e-06	1.45e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	2.32e-06	1.41e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.21e-06	7.3e-06	CbGpPWpGaD
